Shilpa Medicare promoter group releases pledge on 30 lakh shares

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Promoter group released encumbrance on 30,00,000 shares (1.5337% of capital)
  • Release occurred on September 25, 2026, involving pledges with Bajaj Finance Limited
  • Vishnukant C Bhutada had the largest release at 10,00,000 shares
  • Remaining encumbered shares persist for key promoters like Deepak Kumar Innani
powered bylight_fuzz_icon
51958642

*this image is generated using AI for illustrative purposes only.

Shilpa Medicare Ltd promoter group members released the encumbrance on 30,00,000 equity shares, representing 1.5337% of the company's paid-up share capital, on September 25, 2026.

The release pertains to pledged shares that were previously encumbered as collateral for self-loans taken by individual promoters from Bajaj Finance Limited. The disclosure was filed with the stock exchanges on September 26, 2026, under Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Breakdown of released shares

The total release of 30,00,000 shares was distributed across six members of the promoter group. Vishnukant C Bhutada saw the largest single release of 10,00,000 shares, while Dharmavati Bhutada, Deepak Kumar Innani, and Ramakant Innani each had 5,00,000 or 6,00,000 shares released. Om Prakash Innani and Brijgopal Innani each had 2,00,000 shares freed from pledge.

Promoter Name Shares Released % of Share Capital Post-Event Encumbered Shares
Vishnukant C Bhutada 10,00,000 0.5113% 10,00,000
Dharmavati Bhutada 6,00,000 0.3067% 7,50,000
Deepak Kumar Innani 5,00,000 0.2556% 8,50,000
Ramakant Innani 5,00,000 0.2556% 8,50,000
Om Prakash Innani 2,00,000 0.10225% 2,00,000
Brijgopal Innani 2,00,000 0.10225% 2,00,000

Regulatory disclosure details

The filing was submitted to BSE Limited and National Stock Exchange of India Limited. The reason cited for the release in all cases was the repayment or settlement of self-loans for which these shares served as collateral. The entity from which the shares were released is identified as Bajaj Finance Limited in all instances.

What the numbers show

The data indicates a partial reduction in promoter pledging rather than a complete unwinding. For instance, Vishnukant C Bhutada still holds 10,00,000 shares in an encumbered state post-release, which is equal to the number of shares just released. Similarly, Deepak Kumar Innani and Ramakant Innani each retain 8,50,000 encumbered shares after releasing 5,00,000 shares each. This suggests that while liquidity constraints may have eased slightly for specific loan tranches, a significant portion of promoter holdings remains pledged as security.

Historical Stock Returns for Shilpa Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.61%+5.75%+18.42%+199.84%+149.53%+262.43%

Will Shilpa Medicare's remaining pledged shares be fully unwound in the upcoming quarters to reduce promoter risk?

How might this reduction in pledging influence institutional investor sentiment and the stock's valuation multiples?

Are there plans for further share releases by the Bhutada and Innani families as they continue repaying self-loans?

Shilpa Medicare to participate in Nuvama CEO Forum on Sep 28, 2026

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Shilpa Medicare officials will attend the Nuvama Emerging India CEO Forum on September 28, 2026
  • Meetings in Mumbai will include both one-on-one and group sessions with investors
  • The company confirmed that no Unpublished Price Sensitive Information will be disclosed
  • Participation is reported under SEBI Listing Regulations for investor conferences
powered bylight_fuzz_icon
51618910

*this image is generated using AI for illustrative purposes only.

Shilpa Medicare Limited announced that its officials will participate in the Nuvama Emerging India CEO Forum in Mumbai on September 28, 2026. The event provides an opportunity for one-on-one and group meetings with investors and analysts.

The participation is disclosed under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events to ensure market transparency.

Meeting Details

The company outlined the specific parameters of the upcoming engagement in its filing to stock exchanges.

Parameter Detail
Date September 28, 2026
Event Nuvama Emerging India CEO Forum
Location Mumbai
Meeting Type In Person
Format 1x1 and Group Meetings

Disclosure Compliance

Shilpa Medicare stated that no Unpublished Price Sensitive Information (UPSI) will be shared during these meetings. The company noted that the schedule remains subject to change by the organizers, investors, or the company itself.

This intimation was filed with BSE Limited and National Stock Exchange of India Limited on September 22, 2026.

Historical Stock Returns for Shilpa Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.61%+5.75%+18.42%+199.84%+149.53%+262.43%

How might the insights shared at the Nuvama Emerging India CEO Forum influence Shilpa Medicare's upcoming quarterly guidance?

What specific strategic priorities is Shilpa Medicare expected to highlight to institutional investors regarding its API segment growth?

Will the engagement with analysts lead to any revisions in consensus earnings estimates for Shilpa Medicare in the near term?

More News on Shilpa Medicare

1 Year Returns:+149.53%